Morgan Stanley
OGN icon

Morgan Stanley’s Organon & Co OGN Stock Holding History

Morgan Stanley’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8M Sell
2,202,199
-1,090,485
-33% -$13M ﹤0.01% 2729
2026
Q1 		$19.7M Buy
3,292,684
+113,542
+4% +$854K ﹤0.01% 2976
2025
Q4 		$22.8M Sell
3,179,142
-1,178,774
-27% -$9.31M ﹤0.01% 2813
2025
Q3 		$46.5M Sell
4,357,916
-1,388,310
-24% -$13.6M ﹤0.01% 2072
2025
Q2 		$55.6M Buy
5,746,226
+133,652
+2% +$1.38M ﹤0.01% 1819
2025
Q1 		$83.6M Buy
5,612,574
+1,062,407
+23% +$16.3M 0.01% 1380
2024
Q4 		$67.9M Sell
4,550,167
-568,027
-11% -$9.26M ﹤0.01% 1559
2024
Q3 		$97.9M Sell
5,118,194
-183,585
-3% -$3.81M 0.01% 1258
2024
Q2 		$110M Buy
5,301,779
+262,959
+5% +$5.23M 0.01% 1122
2024
Q1 		$94.7M Sell
5,038,820
-820,208
-14% -$14.1M 0.01% 1241
2023
Q4 		$84.5M Buy
5,859,028
+2,823,591
+93% +$38.4M 0.01% 1285
2023
Q3 		$52.7M Buy
3,035,437
+315,464
+12% +$6.58M 0.01% 1527
2023
Q2 		$56.6M Buy
2,719,973
+52,724
+2% +$1.15M 0.01% 1477
2023
Q1 		$62.7M Sell
2,667,249
-345,610
-11% -$9.28M 0.01% 1347
2022
Q4 		$84.1M Sell
3,012,859
-13,440
-0.4% -$344K 0.01% 1133
2022
Q3 		$70.8M Buy
3,026,299
+22,516
+0.7% +$680K 0.01% 1090
2022
Q2 		$101M Buy
3,003,783
+1,011,902
+51% +$35.4M 0.01% 908
2022
Q1 		$69.6M Buy
1,991,881
+138,203
+7% +$4.73M 0.01% 1080
2021
Q4 		$56.4M Sell
1,853,678
-145,572
-7% -$4.74M 0.01% 1256
2021
Q3 		$65.6M Sell
1,999,250
-65,428
-3% -$2.09M 0.01% 1113
2021
Q2 		$62.5M Buy
+2,064,678
New +$68M 0.01% 1154

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Morgan Stanley's OGN Position: Q2 2026 in Review

Morgan Stanley reduced its Organon & Co (OGN) stake by 33% in Q2 2026, selling an estimated $13M and leaving 2,202,199 shares worth $29.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Morgan Stanley first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $110M in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Morgan Stanley held 2,202,199 shares of Organon & Co worth $29.8M as of Q2 2026.
  • Morgan Stanley sold 1,090,485 Organon & Co shares in Q2 2026, an estimated $13M.
  • Organon & Co made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2729 holding.
  • Morgan Stanley first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Morgan Stanley's Organon & Co position peaked at $110M in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.